Premature ovarian failure.
The past 2 years have seen progress in our understanding of the process of premature ovarian failure with identification of molecular causes and clarification of the autoimmune targets within the ovary. With the knowledge that most women with premature ovarian failure have ovarian follicles on ultrasonography, we eagerly await the next therapeutic landmark-the application of the preservation or in-vitro maturation of ova.